Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,598,042
  • Shares Outstanding, K 104,110
  • Annual Sales, $ 482,380 K
  • Annual Income, $ 106,140 K
  • 60-Month Beta 0.44
  • Price/Sales 7.46
  • Price/Cash Flow 34.76
  • Price/Book 6.33
Trade CORT with:

Options Overview Details

View History
  • Implied Volatility 73.15% ( +7.48%)
  • Historical Volatility 43.27%
  • IV Percentile 62%
  • IV Rank 35.77%
  • IV High 156.92% on 05/17/24
  • IV Low 26.50% on 08/03/23
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,985
  • Volume Avg (30-Day) 788
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 21,531
  • Open Int (30-Day) 32,893

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.22
  • Number of Estimates 4
  • High Estimate 0.28
  • Low Estimate 0.20
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.42 +17.47%
on 07/09/24
35.06 -1.43%
on 07/23/24
+4.52 (+15.05%)
since 06/21/24
3-Month
22.00 +57.09%
on 04/25/24
35.22 -1.87%
on 06/06/24
+11.56 (+50.26%)
since 04/23/24
52-Week
20.84 +65.83%
on 04/22/24
35.22 -1.87%
on 06/06/24
+10.72 (+44.97%)
since 07/21/23

Most Recent Stories

More News
Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Insmed, Agios rise; DraftKings, Atlantica fall

CORT : 34.56 (-0.03%)
ET : 16.40 (+0.12%)
USM : 54.01 (-3.33%)
AY : 22.08 (-0.54%)
DKNG : 37.78 (+2.55%)
AGIO : 49.72 (+4.13%)
INSM : 75.99 (-0.38%)
Corcept: Q1 Earnings Snapshot

Corcept: Q1 Earnings Snapshot

CORT : 34.56 (-0.03%)
Corcept: Q4 Earnings Snapshot

Corcept: Q4 Earnings Snapshot

CORT : 34.56 (-0.03%)
Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise, Tuesday, 1/2/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise

BIDU : 90.37 (-2.06%)
PBR-A : N/A (N/A)
PBR : 14.57 (-1.22%)
CORT : 34.56 (-0.03%)
PNM : 40.14 (-0.30%)
JNJ : 152.35 (-1.23%)
ASML : 932.81 (-0.90%)
Corcept: Q3 Earnings Snapshot

Corcept: Q3 Earnings Snapshot

CORT : 34.56 (-0.03%)
Corcept: Q2 Earnings Snapshot

Corcept: Q2 Earnings Snapshot

CORT : 34.56 (-0.03%)
Corcept: Q1 Earnings Snapshot

Corcept: Q1 Earnings Snapshot

CORT : 34.56 (-0.03%)
BridgeBio, Corcept rise; Aclaris Therapeutics, IAA fall

Stocks that traded heavily or had substantial price changes Monday: BridgeBio, Corcept rise; Aclaris Therapeutics, IAA fall

CORT : 34.56 (-0.03%)
BBIO : 27.49 (+3.07%)
ACRS : 1.4000 (+5.26%)
MO : 49.12 (-0.57%)
CIEN : 51.27 (+1.59%)
Corcept: Q4 Earnings Snapshot

Corcept: Q4 Earnings Snapshot

CORT : 34.56 (-0.03%)
NATIONALLY RANKED ROSEN LAW FIRM Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation - CORT

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

CORT : 34.56 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 35.81
2nd Resistance Point 35.43
1st Resistance Point 35.00
Last Price 34.56
1st Support Level 34.19
2nd Support Level 33.81
3rd Support Level 33.38

See More

52-Week High 35.22
Last Price 34.56
Fibonacci 61.8% 29.73
Fibonacci 50% 28.03
Fibonacci 38.2% 26.33
52-Week Low 20.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar